• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma.

作者信息

Deng Jiajun, She Yunlang, Yang Minglei, Zhang Lei, Xie Dong, Chen Chang

机构信息

Department of Thoracic Surgery, Tongji University Affiliated Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.

Department of Thoracic Surgery, Ningbo No. 2 Hospital, Chinese Academy of Sciences, Ningbo, China.

出版信息

Transl Lung Cancer Res. 2020 Aug;9(4):1623-1624. doi: 10.21037/tlcr-20-683.

DOI:10.21037/tlcr-20-683
PMID:32955508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7481646/
Abstract
摘要

相似文献

1
Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma.放射组学：临床 I 期肺腺癌 N2 期恶性肿瘤的潜在生物标志物。
Transl Lung Cancer Res. 2020 Aug;9(4):1623-1624. doi: 10.21037/tlcr-20-683.
2
CT-based radiomics signature for the stratification of N2 disease risk in clinical stage I lung adenocarcinoma.基于CT的影像组学特征用于临床I期肺腺癌N2疾病风险分层
Transl Lung Cancer Res. 2019 Dec;8(6):876-885. doi: 10.21037/tlcr.2019.11.18.
3
Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics.可切除肺腺癌患者的预后预测：CT 放射组学的价值。
Eur Radiol. 2020 Sep;30(9):4952-4963. doi: 10.1007/s00330-020-06872-z. Epub 2020 Apr 30.
4
Radiomics Signature to Predict Prognosis in Early-Stage Lung Adenocarcinoma (≤3 cm) Patients with No Lymph Node Metastasis.预测无淋巴结转移的早期肺腺癌（≤3 cm）患者预后的影像组学特征
Diagnostics (Basel). 2022 Aug 6;12(8):1907. doi: 10.3390/diagnostics12081907.
5
A potential biomarker based on clinical-radiomics nomogram for predicting survival and adjuvant chemotherapy benefit in resected node-negative, early-stage lung adenocarcinoma.一种基于临床-影像组学列线图的潜在生物标志物，用于预测切除的淋巴结阴性早期肺腺癌患者的生存及辅助化疗获益情况。
J Thorac Dis. 2022 Jan;14(1):1-17. doi: 10.21037/jtd-21-1520.
6
Radiomics signature: a biomarker for the preoperative discrimination of lung invasive adenocarcinoma manifesting as a ground-glass nodule.影像组学特征：一种术前鉴别表现为磨玻璃结节的肺浸润性腺癌的生物标志物。
Eur Radiol. 2019 Feb;29(2):889-897. doi: 10.1007/s00330-018-5530-z. Epub 2018 Jul 2.
7
Improving the accuracy of prognosis for clinical stage I solid lung adenocarcinoma by radiomics models covering tumor per se and peritumoral changes on CT.基于 CT 肿瘤本身和瘤周改变的影像组学模型提高临床Ⅰ期实性肺腺癌预后准确性
Eur Radiol. 2022 Feb;32(2):1065-1077. doi: 10.1007/s00330-021-08194-0. Epub 2021 Aug 28.
8
MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma.基于MRI的影像组学列线图作为预测肺腺癌胸椎转移中外显子19和21中表皮生长因子受体（EGFR）突变的潜在生物标志物
Acad Radiol. 2022 Mar;29(3):e9-e17. doi: 10.1016/j.acra.2021.06.004. Epub 2021 Jul 29.
9
An individualised radiomics composite model predicting prognosis of stage 1 solid lung adenocarcinoma.个体化放射组学综合模型预测 1 期实性肺腺癌的预后。
Clin Radiol. 2020 Jul;75(7):562.e11-562.e19. doi: 10.1016/j.crad.2020.03.019. Epub 2020 Apr 16.
10
Decoding tumor mutation burden and driver mutations in early stage lung adenocarcinoma using CT-based radiomics signature.基于 CT 影像组学特征解码早期肺腺癌的肿瘤突变负荷和驱动突变。
Thorac Cancer. 2019 Oct;10(10):1904-1912. doi: 10.1111/1759-7714.13163. Epub 2019 Aug 14.

本文引用的文献

1
Can CT radiomics differentiate benign from malignant N2 adenopathy in non-small cell lung cancer.CT影像组学能否鉴别非小细胞肺癌中N2淋巴结病变的良恶性？
Transl Lung Cancer Res. 2020 Oct;9(5):1710-1711. doi: 10.21037/tlcr-20-477.
2
CT-based radiomics signature for the stratification of N2 disease risk in clinical stage I lung adenocarcinoma.基于CT的影像组学特征用于临床I期肺腺癌N2疾病风险分层
Transl Lung Cancer Res. 2019 Dec;8(6):876-885. doi: 10.21037/tlcr.2019.11.18.
3
Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.cN0 期非小细胞肺癌中最大标准化摄取值与隐匿性纵隔淋巴结转移的相关性
Eur J Cardiothorac Surg. 2016 Nov;50(5):914-919. doi: 10.1093/ejcts/ezw109. Epub 2016 Apr 24.
4
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.国际肺癌研究协会肺癌分期项目：对即将发布的第 8 版肺癌 TNM 分类中 N 描述符修订的建议。
J Thorac Oncol. 2015 Dec;10(12):1675-84. doi: 10.1097/JTO.0000000000000678.
5
Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer?正电子发射断层扫描能否避免对临床ⅠA期肺癌进行非治疗性肺切除术？
Ann Thorac Surg. 2008 Apr;85(4):1166-9; discussion 1169-70. doi: 10.1016/j.athoracsur.2008.01.018.